Analyst Ratings for Regeneron Pharma (REGN)
REGN Rating Summary
REGN Price Target Summary
- Highest: $995.00 (Guggenheim)
- Lowest: $641.00 (Leerink)
- Average: $824.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$824.44 (+35.2%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | Leerink | Andrew Berens | Downgrade | Market Perform (Outperform) |
641.00 (N/A) |
698.25 (609.94) |
-12.65% | Details |
| 5/18/2026 | Citi | Geoff Meacham | Downgrade | Neutral (Buy) |
700.00 (900.00) |
712.87 (609.94) |
-14.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
